Clinical Trial Update: ASIS for GAMMAGARD in Primary Immunodeficiency [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on GAMMAGARD for primary immunodeficiency, covering Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• GAMMAGARD (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: ASIS Corporation | Conditions: Primary Immunodeficiency | Phase 1, Phase 2 | Status: UNKNOWN